tixestobart
Generic: Tixestobart
tixestobart: 1 clinical trial tracked.
tixestobart evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about tixestobart, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
Clinical Trial Registry Records (1)
First-in-Human, Open-label, Dose-Escalation Trial With an Expansion Cohort to Evaluate the Safety of GEN1053 as Monotherapy in Subjects With Malignant Solid Tumors
Primary endpoint: Number of Participants With Dose Limiting Toxicities (DLTs)
Interventionalopen31 targetStarted 2022-10Completion 2024-055 sites · Spain, United StatesGenmab